Back to Search
Start Over
CircRNA7632 down-regulation alleviates endothelial cell dysfunction in Kawasaki disease via regulating IL-33 expression.
- Source :
-
Cell stress & chaperones [Cell Stress Chaperones] 2023 Jul; Vol. 28 (4), pp. 363-374. Date of Electronic Publication: 2023 May 11. - Publication Year :
- 2023
-
Abstract
- Kawasaki disease (KD) is a form of idiopathic vasculitis frequently accompanied by coronary artery lesions, which involves endothelial dysfunction. Recent studies have demonstrated that circular RNAs (circRNAs) are implicated in many cardiovascular diseases. However, few studies have examined the role of circRNAs on endothelial dysfunction in KD. In this study, we investigated the role of circ7632 on endothelial-mesenchymal transition (EndoMT) in KD and then explored the underlying mechanism. Children diagnosed with KD and age-matched healthy controls (HC) were included. Sera samples were collected. Primary human umbilical vein endothelial cells (HUVECs) were obtained and incubated with 15% HC and KD serum for 48 h. The mRNA and protein expression of mesenchymal markers vimentin and α-smooth muscle actin (α-SMA) and endothelial marker zonula occludens-1 (ZO-1) in HUVECs transfected with plasmid-circ7632 and si-circ7632 were detected by RT-qPCR and Western blot analysis. CCK8, scratch test, and migration test were performed to examine the effect of circ7632 on the cell proliferation and migration. The circ7632 level was higher in HUVECs treated by KD serum than in HUVECs treated with HC serum. Overexpression of circ7632 significantly increased vimentin and α-SMA expression, decreased ZO-1 expression, and also decreased cell proliferation. Down-regulation of circ7632 expression got the opposite results. RNA-seq analysis, and confirmatory experiment displayed that down-regulation of circ7632 decreased IL-33 expression, and IL-33 silencing mitigated KD serum-mediated EndoMT. Our study revealed that circ7632 level was elevated in KD serum-treated HUVECs. Circ7632 down-regulation could alleviate EndoMT likely through decreasing IL-33 expression. The circ7632 may become a potential therapeutic target for KD.<br /> (© 2023. The Author(s), under exclusive licence to Cell Stress Society International.)
- Subjects :
- Child
Humans
Vimentin genetics
Vimentin metabolism
Vimentin pharmacology
Down-Regulation
Interleukin-33 genetics
Interleukin-33 metabolism
Interleukin-33 pharmacology
RNA, Circular genetics
RNA, Circular metabolism
Human Umbilical Vein Endothelial Cells metabolism
Mucocutaneous Lymph Node Syndrome genetics
Mucocutaneous Lymph Node Syndrome pathology
Subjects
Details
- Language :
- English
- ISSN :
- 1466-1268
- Volume :
- 28
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Cell stress & chaperones
- Publication Type :
- Academic Journal
- Accession number :
- 37166618
- Full Text :
- https://doi.org/10.1007/s12192-023-01333-0